The DeepTCM1.0 framework was applied to the mechanistic interpretation of Guizhi Decoction from the dual perspectives of classical traditional Chinese medicine theory and modern scientific research, enabling systematic and interpretable mechanistic analysis of TCM compound formulas.
Abstract
Background: Mechanistic elucidation of traditional Chinese medicine (TCM) compound formulas remains a central challenge in the modernization of TCM. Conventional approaches, including data mining and network pharmacology, are insufficient for achieving deep integration between classical TCM theory and modern scientific research. In addition, direct question-answering using general-purpose artificial intelligence large language models is limited by inadequate adaptation to TCM theoretical frameworks and susceptibility to reasoning hallucinations. Consequently, there is an urgent need to develop intelligent analytical methods aligned with the holistic principles of TCM. Objective: To establish a multi-expert intelligent agent framework integrating classical TCM theory with modern life sciences, thereby enabling systematic and interpretable mechanistic analysis of TCM compound formulas, with Guizhi Decoction serving as a representative validation case. Methods: The DeepTCM1.0 framework was constructed based on the general-purpose large language model DeepSeek V3.2. It adopts a three-tier collaborative architecture and a three-round iterative quality-control workflow, simulating the collaborative analytical process of 11 interdisciplinary intelligent agents. The framework was applied to the mechanistic interpretation of Guizhi Decoction from the dual perspectives of classical traditional Chinese medicine theory and modern scientific research. Framework performance was comprehensively evaluated through double-blind five-dimensional scoring, intraclass correlation coefficient (ICC) reliability testing, Mann-Whitney U tests, and effect size analysis. The evaluation employed four independent large language models as evaluators, each conducting five rounds of repeated scoring on five anonymized reports, resulting in a total of 100 independent scoring assessments.
The core formula likely exerts therapeutic effects via multi-target mechanisms involving ESR1 and TP53 through key signaling pathways, offering a mechanistic explanation for its clinical efficacy against MPS.
E. Zhang, Ya-Xue Xu, Ping Chen et al.· International Journal of Wom...· 0 citations
The unique advantage of traditional Chinese medicine (TCM) lies in its overall regulatory properties, which makes it particularly promising in the treatment of complex diseases. However, for a long time, the discovery of TCM drugs has been limited by inefficient, experience-driven methods and experimental screening met...
Tianyu Chen· Theoretical and Natural Scie...· 0 citations
AI and big-data methods are being used to reshape selected stages of antidiabetic ethnopharmacology, particularly candidate prioritization, target prediction, and network-based mechanism generation, however, most evidence remains hypothesis-generating.
R. M. Febriyanti, A. A. Irawan, Ami Tjitraresmi et al.· Discover Artificial Intellig...· 0 citations
Biomimetic sensors offer a rapid route for estimating active constituent contents in Chinese medicinal materials, but their practical use at procurement sites and production workshops is constrained by small and skewed datasets, repeated task-specific model configuration, and the limited operational traceability of man...
Xuemei Yin, Pengfei Song, Xiao Luo et al.· Chemosensors· 0 citations
Findings suggest that DJC may attenuate DN in part through CCL2/C-C motif chemokine receptor 2 (CCR2)-related pyroptosis signaling changes, which is associated with inflammatory responses and the MAPK pathway.
Zi-Qiang Li, Ying Yuan, Yueyue Zhao et al.· Journal of Visualized Experi...· 0 citations
In Parkinson's disease (PD), where complex mechanisms and limited targets hamper therapy development, XunZi identifies aberrant activation of CHK2 and IRAK4 kinases across multiple models and establishes a paradigm-shifting framework to translate fragmented biomedical knowledge and data into actionable therapeutics.